Alvotech, a global biotech company specializing in biosimilars, will report its financial results for the nine months and third quarter ending September 30, 2026, on November 11 after the U.S. market closes. The company will host a webcast and live Q&A session on November 12 to discuss the results. Alvotech focuses on developing cost-effective biosimilar medicines and has five approved biosimilars marketed globally. This earnings report will provide insights into the company’s financial health and progress in its biosimilar pipeline.
Alvotech's upcoming financial results report provides context for readers interested in biotech developments. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 17:41 WIB: out of 150 priced US health stocks tradable on Pluang, 42 rose and 94 fell. Notable movers include IMVT at USD 29.40 with a 1-day change of +1.80% and a typical hold time of 19 days, AVTR at USD 16.85 down 1.63% with an 11-day hold, and COR at USD 320.51 down 1.49% with an 8-day hold time.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
